A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids

References 

1. www.who.int/chp/topics/rheumatic/en (last accessed April 20,2010).
2. American Geriatric Society (AGS) Panel on pharamcological management of persistent pain in older persons. J Amer Geriatc Soc 2009; 67: 1331-46.
3. 2008 European Guidelines for primary care management of chronic osteoarthritis pain. http://www.eGuidelines.co.uk (last accessed April 29,2010).
4. The American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update. Arthritis & Rheumatism, 2000; 43:1905-15.
5. Kalso E, Edwards JE, Moore A, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380
   • Abstract
   • Full Text
   • Full-Text PDF (268 KB)
   • CrossRef
6. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews 2010, Issue 1. Art.No.: CD006605. DOI: 10.1002/14651858. CD006605.pub2.
7. Peloso PM, Fortin L, Beaulieu A, Kamin M Rosenthal N Protocol TRP-CAN-1 Study Group. Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol. 2004;31:2454–2463
   • MEDLINE
8. Kress HG. Clinical update on the pharmacology, efficacy and safethy of transdermal buprenorphine. Eur J Pain. 2009;13:219–230
   • CrossRef
9. Kellgren JH, Lawrence JS. Osteo-arthrosis and disk degeneration in an urban population. Ann Rheum Dis. 1958;17:388–397
   • MEDLINE
   • CrossRef
10. Declaration of Helsinki. Ethical principles for medical research involving human subjects. World Medical Association Website: http://www.wma.net/e/policy/b3.htm.
11. ICH Topic E6 (R1): Guidelines for good clinical practice: Consolidated Guideline. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Website: http://www.ich.org/LOB/media/MEDIA482.pdf.
12. Bellamy N, Buchnan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840
    • MEDLINE
13. Söderman P, Malchau H. Validity and reliability of Swedish WOMAC osteoarthritis index: A self-administered disease-specific questionnaire (WOMAC) versus generic instruments (SF-36 and NHP). Acta Orthopaedica Scand. 2000;71:39–46
14. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. McConnell, Kolopack, Davis. Arthritis Care & Research, 2001; 45:453-61.
15. Hurst NP, Kind P, Ruta PA, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQoL (EQ-5D). Brit J Rheumatol. 1997;36:551–559
16. Breivik EK, Barkvoll P, Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Thr. 1999;66:625–635
17. Ong CKS, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonstroidal antiinflammatory drugs: A qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010;110:1170–1179
18. Stubhaug A, Breivik H. Clinical trials: Acute and chronic pain. In:  Breivik H,  Campbell W,  Nicholas M editor. Clinical Management of Pain – Practice and Procedures. 2nd ed. London: Hodder-Arnold; 2008;p. 514–528
19. Hals EKB. Clinical trials: Dental pain. In:  Breivik H,  Campbell W,  Nicholas M editor. Clinical Management of Pain – Practice and Procedures. 2nd ed.. London: Hodder-Arnold; 2008;p. 529–537
20. Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006;296:87–93
    • CrossRef
21. Kaasa T, Romundstad L, Breivik H. New therapeutic principles for adverse effects on upper and lower gastrointestinal tract in patients treated with opioid analgesics. Scand J Pain. 2009;Supple 1:S12–S17
22. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, et al. Assessment of pain. Br J Anaesth. 2008;101:17–24
    • CrossRef
23. Allen KD, Coffman CJ, Golightly YM, Stechuchak KM, Voils CI, Keefe FJ. Comparison of pain measures among patients with osteoarthritis. J Pain. 2009 (in press- available online at www.sciencedirect.com April 20, 2010).
24. Kidd BL, Langford RM, Wodehouse T. Arthritis and pain. Current approaches in the treatment of arthritic pain. Arthritis Res Ther. 2007;9:214–227
25. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237–251
    • Abstract
    • Full Text
    • Full-Text PDF (195 KB)
    • CrossRef
26. Skurtveit S, Furu K, Kaasa S, Borchgrevink PC. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?. Eur J Pain. 2009;13:949–953
    • CrossRef
27. Pergolizzi J, Aloisi AM, Dahan A, Filitz J, Langford R, Likar R, Mercadante S, Morloin B, Raffa RB, Sabatowski R, Sacerdote P, Torres LM, Weinbroum AA. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract 2010 (Epub ahead of print. PMID: 20492579. doi:10.1111/j.15333-2500.2010.00378.x).